• AstraZeneca PLC
  •  Overview
  • Last Modified:
  • June 30, 2025
  • Company type:
  • Public
  • Industry:
  • Pharmaceutical
  • Verified:
  • No
  • No of Employees:
  • 50 001 - 100 000
  • Stock Code:
  • AZN
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • Cambridge, United Kingdom
  • Public Interest Score:
  • 750+

 

  • AstraZeneca PLC
  • General Information

Description

AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

We are more than 80,000 people in over 100 countries. Our aim is simple: to positively impact lives, together. Using the power of science and innovation, our people improve the impact medicine has on patients. Together, we explore the limitless world of science through our impressive product pipeline and we take our understanding of many therapeutic areas to a whole new level by seeking new treatments.

Michel Demare:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Pascal Soriot:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Aradhana Sarin:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Philip Broadley:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Euan Ashley:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Deborah Eldracher:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Diana Layfield:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anna Manz:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sherilyn McCoy:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Tony Mok:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nazneen Rahman:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Andreas Rummelt:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Marcus Wallenberg:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 14816
  • Founded Year: 
  • 1999
  • Registration Number: 
  • 02723534
  • Country: 
  • United Kingdom of Great Britain and Northern Ireland (the)
  • Stock Exchanges: 
    • London Stock Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 16
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Pharmaceutical
  • Date listed on Stock Exchange: 
  • 01/06/1993

 

  • Contact Information
  • Business operation: 
  • Global, science-led, patient-focused pharmaceutical business, committed to excellence in the research, development and commercialisation of prescription medicines.
  • Primary office: 
  • 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA UK

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Matthew Bowden
  • Reporting currency: 
  • USD
  • ISIN number (12 digit): 
LSE
GB0009895292
  • Authorised shares:
  • Issued shares:
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Moody'sCredit LogoUnited States of AmericaNew YorkA2
S and P RatingsCredit LogoUnited States of AmericaNew YorkA

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Michel

Non Executive
NationalityBelgium
70
RoleNED
QualificationMBA; degree in applied economics
Date Appointed: 01/01/2019
Duration:
7 years and 8 months
Independance: Y
Profile
Name

Pascal

Executive
NationalityFrance
67
RoleCEO
QualificationDoctor of Veterinary Medicine, MBA
Date Appointed: 01/01/2012
Duration:
14 years and 8 months
Independance: N
Profile
Name

Aradhana

Executive
NationalityIndia
51
RoleED
QualificationMD, MBA
Date Appointed: 01/01/2021
Duration:
5 years and 8 months
Independance: Y
Profile
Name

Philip Arthur John

Non Executive
NationalityNew Zealand
65
RoleNED
QualificationMSc in Behavioural Science from the London School of Economics
Date Appointed: 01/01/2017
Duration:
9 years and 8 months
Independance: Y
Profile
Name

Euan

Non Executive
NationalityNew Zealand
RoleNED
QualificationPhysiology and MD, DPhil in cardiovascular cellular biology and molecular genetics
Date Appointed: 01/01/2020
Duration:
6 years and 8 months
Independance: Y
Profile
Name

Deborah DiSanzo

Non Executive
NationalityAmerican
66
RoleNED
QualificationMBA
Date Appointed: 01/01/2016
Duration:
10 years and 8 months
Independance: N
Profile
Name

Layfield

Non Executive
NationalityUnited Kingdom
RoleNED
QualificationBA, MA in Public Administration and International Economics
Date Appointed: 01/01/2020
Duration:
6 years and 8 months
Independance: Y
Profile
Name

Anna

Non Executive
NationalityUnited Kingdom
RoleNED
QualificationMasters degree in chemistry
Date Appointed: 01/09/2023
Duration:
3 years and 0 month
Independance: Y
Profile
Name

Sherilyn S. D.

Non Executive
NationalityNew Zealand
67
RoleNED
QualificationBS,MSCHE, MBA
Date Appointed: 01/01/2017
Duration:
9 years and 8 months
Independance: Y
Profile
Name

Tony

Non Executive
NationalityTaiwan
65
RoleNED
QualificationBachelor of Medical Science degree, MD
Date Appointed: 01/01/2019
Duration:
7 years and 8 months
Independance: Y
Profile
Name

Nazneen

Non Executive
NationalityUnited Kingdom
58
RoleNED
QualificationMD, Certificate of Completion of Specialist Training in medical genetics, PhD in molecular genetics
Date Appointed: 01/01/2017
Duration:
9 years and 8 months
Independance: Y
Profile
Name

Andreas

Non Executive
NationalityFrance
RoleNED
QualificationPhD pharmaceutical sciences
Date Appointed: 01/01/2021
Duration:
5 years and 8 months
Independance: Y
Profile
Name

Marcus

Executive
NationalitySweden
71
RoleVP
QualificationB.Sc. degree in Foreign Services
Date Appointed: 01/01/1999
Duration:
27 years and 8 months
Independance: N
Profile

 

Directors Tenure

Name
Duration
Name

Michel Demare

Duration7 years and 8 months
Profile
Name

Pascal Soriot

Duration14 years and 8 months
Profile
Name

Aradhana Sarin

Duration5 years and 8 months
Profile
Name

Philip Arthur John Broadley

Duration9 years and 8 months
Profile
Name

Euan Ashley

Duration6 years and 8 months
Profile
Name

Deborah DiSanzo Eldracher

Duration10 years and 8 months
Profile
Name

Layfield Diana

Duration6 years and 8 months
Profile
Name

Anna Manz

Duration3 years and 0 month
Profile
Name

Sherilyn S. D. McCoy

Duration9 years and 8 months
Profile
Name

Tony Mok

Duration7 years and 8 months
Profile
Name

Nazneen Rahman

Duration9 years and 8 months
Profile
Name

Andreas Rummelt

Duration5 years and 8 months
Profile
Name

Marcus Wallenberg

Duration27 years and 8 months
Profile

 

Director Experience

Name
Experience
Name

Michel

Experience Chemicals, Technology
Profile
Name

Pascal

Experience Pharmaceutical, Other
Profile
Name

Aradhana

Experience Pharmaceutical
Profile
Name

Philip Arthur John

Experience Business Services
Profile
Name

Euan

Experience Pharmaceutical, Technology
Profile
Name

Deborah DiSanzo

Experience Other, Consumer Services
Profile
Name

Layfield

Experience Pharmaceutical, Business Services
Profile
Name

Sherilyn S. D.

Experience Pharmaceutical, Other
Profile
Name

Tony

Experience Pharmaceutical, Healthcare
Profile
Name

Nazneen

Experience Pharmaceutical, Healthcare
Profile
Name

Andreas

Experience Pharmaceutical
Profile
Name

Marcus

Experience Pharmaceutical, Business Services
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

PwC

Date Appointed01/01/2017
Year9 years and 8 months
Profile

 

 

Company Committees

Name

Michel Demare

Mainboard, Audit, Remuneration BD, SB
Profile
Name

Pascal Soriot

Mainboard, Audit, Remuneration BD
Profile
Name

Aradhana Sarin

Mainboard, Audit, Remuneration BD
Profile
Name

Philip Arthur John Broadley

Mainboard, Audit, Remuneration BD, AU, RE, NG
Profile
Name

Euan Ashley

Mainboard, Audit, Remuneration BD, AU, NG, OT
Profile
Name

Deborah DiSanzo Eldracher

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Layfield Diana

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Anna Manz

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Sherilyn S. D. McCoy

Mainboard, Audit, Remuneration BD, AU, RE, NG, OT
Profile
Name

Tony Mok

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Nazneen Rahman

Mainboard, Audit, Remuneration BD, RE, IS, NG, OT
Profile
Name

Andreas Rummelt

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Marcus Wallenberg

Mainboard, Audit, Remuneration BD, IS, OT
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT